BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33482676)

  • 1. Efficacy and Safety of D-dimer, Weight, and Renal Function-Adjusted Thromboprophylaxis in Patients with Coronavirus Disease 2019 (COVID-19).
    Arachchillage DRJ; Shi C; Saliu D; Kozman P; Mi E; Buti N; Kashef E; Copley SJ; Gomez C; Leonard R; Aziz R; Shlebak AA; Laffan M
    Semin Thromb Hemost; 2021 Jun; 47(4):436-441. PubMed ID: 33482676
    [No Abstract]   [Full Text] [Related]  

  • 2. Prothrombotic disturbances of hemostasis of patients with severe COVID-19: A prospective longitudinal observational study.
    Hardy M; Michaux I; Lessire S; Douxfils J; Dogné JM; Bareille M; Horlait G; Bulpa P; Chapelle C; Laporte S; Testa S; Jacqmin H; Lecompte T; Dive A; Mullier F
    Thromb Res; 2021 Jan; 197():20-23. PubMed ID: 33161283
    [No Abstract]   [Full Text] [Related]  

  • 3. Coronavirus Disease 2019, Prothrombotic Factors, and Venous Thromboembolism.
    Schulman S
    Semin Thromb Hemost; 2020 Oct; 46(7):772-776. PubMed ID: 32392613
    [No Abstract]   [Full Text] [Related]  

  • 4. Maintaining Hemostasis and Preventing Thrombosis in Coronavirus Disease 2019 (COVID-19): Part II.
    Favaloro EJ; Lippi G
    Semin Thromb Hemost; 2021 Jun; 47(4):333-337. PubMed ID: 34062596
    [No Abstract]   [Full Text] [Related]  

  • 5. Thromboelastography-Guided Management of Anticoagulated COVID-19 Patients to Prevent Hemorrhage.
    Stillson JE; Bunch CM; Gillespie L; Khan R; Wierman M; Pulvirenti J; Phyu H; Anderson S; Al-Fadhl M; Thomas AV; Kwaan HC; Moore E; Moore H; Walsh MM
    Semin Thromb Hemost; 2021 Jun; 47(4):442-446. PubMed ID: 33607668
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of COVID-19 coagulopathy; laboratory characterization using thrombin generation and nonconventional haemostasis assays.
    White D; MacDonald S; Edwards T; Bridgeman C; Hayman M; Sharp M; Cox-Morton S; Duff E; Mahajan S; Moore C; Kirk M; Williams R; Besser M; Thomas W
    Int J Lab Hematol; 2021 Feb; 43(1):123-130. PubMed ID: 32892505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin Effect on Interleukin-10 Levels in Iraqi Patients with COVID-19: A Case-Control Study.
    Al-Hashimi NH; Al-Hindawi MS; Mohsen AM; Al-Gebori AM
    Front Biosci (Schol Ed); 2024 Apr; 16(2):9. PubMed ID: 38939974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D-dimer at hospital admission for COVID-19 are associated with in-hospital mortality, independent of venous thromboembolism: Insights from a French multicenter cohort study.
    Chocron R; Duceau B; Gendron N; Ezzouhairi N; Khider L; Trimaille A; Goudot G; Weizman O; Alsac JM; Pommier T; Bory O; Cellier J; Philippe A; Geneste L; Ben Abdallah I; Panagides V; El Batti S; Marsou W; Juvin P; Deney A; Messas E; Attou S; Planquette B; Mika D; Gaussem P; Fauvel C; Diehl JL; Pezel T; Mirault T; Sutter W; Sanchez O; Bonnet G; Cohen A; Smadja DM;
    Arch Cardiovasc Dis; 2021 May; 114(5):381-393. PubMed ID: 33846096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Enoxaparin on D-dimer levels in hospitalized Corona Virus patients with a comparison of its level in patients with comorbid conditions.
    Khaleq MAA
    Wiad Lek; 2024; 77(4):828-833. PubMed ID: 38865643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal Disseminated Intravascular Coagulopathy in Covid-19: A Small Case Series.
    Kazmi S; Herekar F; Sarfaraz S
    Semin Thromb Hemost; 2021 Jun; 47(4):427-430. PubMed ID: 33336328
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence-Based Practical Guidance for the Antithrombotic Management in Patients With Coronavirus Disease (COVID-19) in 2020.
    Ramacciotti E; Macedo AS; Biagioni RB; Caffaro RA; Lopes RD; Guerra JC; Orsi FA; Marques MA; Tafur AJ; Caprini JA; Nicolaides A; Carter CA; Filho CC; Fareed J
    Clin Appl Thromb Hemost; 2020; 26():1076029620936350. PubMed ID: 32649232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronavirus Disease 2019: Hematological Anomalies and Antithrombotic Therapy.
    Ornelas-Ricardo D; Jaloma-Cruz AR
    Tohoku J Exp Med; 2020 Aug; 251(4):327-336. PubMed ID: 32788506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
    Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
    J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombocytopenia and thrombosis in hospitalized patients with COVID-19.
    Mei H; Luo L; Hu Y
    J Hematol Oncol; 2020 Dec; 13(1):161. PubMed ID: 33261634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma Antithrombin Values Are Significantly Decreased in Coronavirus Disease 2019 (COVID-19) Patients with Severe Illness.
    Lippi G; Henry BM; Sanchis-Gomar F
    Semin Thromb Hemost; 2021 Jun; 47(4):460-462. PubMed ID: 33378783
    [No Abstract]   [Full Text] [Related]  

  • 16. Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients.
    Dujardin RWG; Hilderink BN; Haksteen WE; Middeldorp S; Vlaar APJ; Thachil J; Müller MCA; Juffermans NP
    Thromb Res; 2020 Dec; 196():308-312. PubMed ID: 32977128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D-dimer Level and Diabetes in the COVID-19 Infection.
    Miri C; Charii H; Bouazzaoui MA; Laouan Brem F; Boulouiz S; Abda N; Kouismi H; Bazid Z; Ismaili N; El Ouafi N
    Clin Appl Thromb Hemost; 2021; 27():10760296211045902. PubMed ID: 34590493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic anticoagulation is not associated with a reduced risk of acute kidney injury in hospitalised Covid-19 patients.
    Parker K; Hamilton P; Hanumapura P; Castelino L; Murphy M; Challiner R; Thachil J; Ebah L
    BMC Nephrol; 2021 Jun; 22(1):224. PubMed ID: 34134645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does Chronic Treatment with Oral Anticoagulants Ameliorate the Clinical Course of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Coronavirus Disease 2019 (COVID-19)?
    Harenberg J; Bauersachs R; Ageno W
    Semin Thromb Hemost; 2021 Jun; 47(4):338-340. PubMed ID: 32882715
    [No Abstract]   [Full Text] [Related]  

  • 20. Systematic assessment of venous thromboembolism in COVID-19 patients receiving thromboprophylaxis: incidence and role of D-dimer as predictive factors.
    Artifoni M; Danic G; Gautier G; Gicquel P; Boutoille D; Raffi F; Néel A; Lecomte R
    J Thromb Thrombolysis; 2020 Jul; 50(1):211-216. PubMed ID: 32451823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.